Product Description

Seretide Diskus and associated names (see Annex I) contain salmeterol and fluticasone propionate, a fixed dose combination of the long acting beta-agonist salmeterol and the inhaled corticosteroid fluticasone propionate and is indicated for the regular treatment of asthma where use of a combination product (long-acting beta-2-agonist and inhaled corticosteroid) is appropriate: – patients not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short acting beta-2-agonist or – patients already adequately controlled on both inhaled corticosteroid and long-acting beta-2-agonist.